Protecting Americans from Unsafe Drugs Act of 2026

Maxine Dexter

Democrat · OR · Representative

Source: Congress.gov · FEC

No cosponsors on record. Bills can pass without cosponsors — this often means the sponsor introduced the bill alone, either because it's a messaging bill, a chairman's mark, or simply early in the legislative cycle.

Referred to the House Committee on Energy and Commerce.

2026-03-18

Source: Congress.gov

This bill would strengthen the Food and Drug Administration's ability to remove dangerous medications from the market more quickly and require drug manufacturers to report safety problems faster to federal regulators. It would affect pharmaceutical companies, patients taking medications, and healthcare providers by establishing stricter standards for keeping unsafe drugs available to the public. The goal is to prevent people from being harmed by medications that pose serious health risks.

AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.

[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [H.R. 7980 Introduced in House (IH)] <DOC> 119th CONGRESS 2d Session H. R. 7980 To amend the Federal Food, Drug, and Cosmetic Act to expand certain authorities with respect to the recall of controlled substances to apply with respect to all drugs, and for other purposes. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES March 18, 2026 Ms. Dexter introduced the following bill; which was referred to the Committee on Energy and Commerce _______________________________________________________________________ A BILL To amend the Federal Food, Drug, and Cosmetic Act to expand certain authorities with respect to the recall of controlled substances to apply with respect to all drugs, and for other purposes. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Protecting Americans from Unsafe Drugs Act of 2026''. SEC. 2. NOTIFICATION, NONDISTRIBUTION, AND RECALL OF DRUGS. (a) Order To Cease Distribution and Recall.--Section 569D of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360bbb-8d) is amended-- (1) in the section heading, by striking ``controlled substances'' and inserting ``drugs''; (2) by striking ``controlled substance'' each place such term appears and inserting ``drug''; (3) in subsection (b)-- (A) by striking ``controlled substances'' and inserting ``drugs''; and (B) by inserting ``of subsection (a)'' after ``an order pursuant to paragraph (1) or an amended order pursuant to subparagraph (B) or (C) of paragraph (3)''; and (4) in subsection (c), by striking ``or an official senior to such Director'' and inserting ``or the Director of the Center for Biologics Evaluation and Research (or an official senior to either such Director)''. (b) Imports and Exports.--Section 801(a) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 381(a)) is amended by striking ``is a controlled substance subject to an order under section 569D'' and inserting ``is a drug subject to an order under section 569D''. <all>

• HR3869Every Veteran Housed Act
  Referred to Committee · 2026-05-20
• HCONRES91Directing the President, pursuant to section 5(c) of the War Powers Resolution, to remove United States Armed Forces from hostilities with Iran.
  Referred to Committee · 2026-04-27
• HR8370Dietary Supplement Listing Act of 2026
  Referred to Committee · 2026-04-20
• HRES1169Honoring the 2026 Olympians and Paralympians from Oregon.
  Referred to Committee · 2026-04-14